4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
9.26 USD
↘ 0.45 (4.63%)🟢LIVE (AS OF 01:35 PM EDT)
🟢Market: OPEN
Open?$9.42
High?$9.49
Low?$9.22
Prev. Close?$9.71
Volume?141.2K
Avg. Volume?722.8K
VWAP?$9.33
Rel. Volume?0.20x
Bid / Ask
Bid?$9.30 × 100
Ask?$9.37 × 200
Spread?$0.07
Midpoint?$9.34
Valuation & Ratios
Market Cap?507.6M
Shares Out?52.3M
Float?50.4M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?1.12
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $9.26. FDMT shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Jun 2, 2026.

News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Clinical-Stage Platforms
Employees
196
Market Cap
518.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.4dmoleculartherapeutics.com
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
61
Momentum?
45
Short Sent.?
19
Piotroski F-Score?1/9Weak
Altman Z-Score?2.71Grey
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.96%Squeeze Risk
Short Interest?12.1M
Days to Cover?19.1
Free Float50.4M
Avg Daily Volume633.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?9.34Strong
Quick Ratio?9.34Strong
Cash Ratio?1.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.12CHEAP▾
P/S?
Peers
100
S&P
24
5.75FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.5CHEAP▾
EV/Sales?
Peers
100
S&P
37
4.93FAIR▾
Returns & Efficiency
ROE?
S&P
5
-35.6%WEAK▾
ROA?
S&P
3
-31.4%WEAK▾
Cash Flow & Enterprise
FCF?$-129544000
Enterprise Value?$435.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist